Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Clark

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
Neuroreport|July 8, 1996
Structure and alternative splicing of the presenilin-2 geneG Prihar, R A Fuldner, J Perez-Tur, et al.
Neuroreport|February 29, 1996
Complete analysis of the presenilin 1 gene in early onset Alzheimer's diseaseM Hutton, F Busfield, M Wragg, et al.
Journal of Medicinal Chemistry|November 16, 2001
Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogensZ Ma, R F Clark, A Brazzale, et al.
Current Pharmaceutical Design|April 10, 1999
Discovery of ascomycin analogs with potent topical but weak systemic activity for treatment of inflammatory skin diseasesK W Mollison, T A Fey, D M Gauvin, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
Neuroreport|July 8, 1996
Structure and alternative splicing of the presenilin-2 geneG Prihar, R A Fuldner, J Perez-Tur, et al.
Neuroreport|February 29, 1996
Complete analysis of the presenilin 1 gene in early onset Alzheimer's diseaseM Hutton, F Busfield, M Wragg, et al.
Journal of Medicinal Chemistry|November 16, 2001
Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogensZ Ma, R F Clark, A Brazzale, et al.
Current Pharmaceutical Design|April 10, 1999
Discovery of ascomycin analogs with potent topical but weak systemic activity for treatment of inflammatory skin diseasesK W Mollison, T A Fey, D M Gauvin, et al.
Pageof 12